TRUSYNERGY

Lobbying for BURRELL INTERNATIONAL GROUP LLC (ON BEHALF OF SHIONOGI INC.) · Government relations & lobbying

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income · posted Oct 13, 2025

Lobbying activity 1

Pharmacy

Funding for the SNS, BARDA, and IBMSC; promoting safer and more effective treatments in the stockpile; promoting onshoring and domestic manufacturing of medicines and their components; prioritizing investments in more effective treatments to combat AMR; PASTEUR Act; reauthorization of the Pandemic and All Hazards Preparedness Act; funding and incentives for MCM development; AMR issues; development of infectious disease and AMR treatments; FY 26 LHHS appropriations; Rare Pediatric Disease Priority Review Voucher

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.